The kinase drug discovery solutions market is projected to reach $0.74 billion by 2030 at a 7.5% CAGR, driven by AI-based target discovery and precision oncology demand.
Read More
The JAK3 inhibitor market is projected to reach $14.91 billion by 2030 at a 12.5% CAGR, driven by precision immunology, safer therapies, and expanded autoimmune indications.
Read More
The interleukin-2 (IL-2) mutein therapies market is set to reach $1.43 billion by 2030 at a 14.4% CAGR, driven by personalized immunotherapy and safer biologics.
Read More
The In Silico Drug Discovery market size is expected to reach $7.42 billion in 2030 at a CAGR of 12.1%, driven by pharma R&D investments.
Read More
The Human Osteoblasts market size is expected to reach $53.09 billion in 2030 at a CAGR of 8.2%, driven by rising bone disease prevalence.
Read More
The High-Throughput Screening Services market size is expected to reach $39.06 billion in 2030 at a CAGR of 11.2%, driven by chronic disease prevalence.
Read More
The Hemophilia B Gene Therapy market size is expected to reach $2.01 billion in 2030 at a CAGR of 29.8%, driven by expanding gene therapy trials.
Read More
The Group B Streptococcus Infection Treatment market size is expected to reach $1.89 billion in 2030 at a CAGR of 8.6%, driven by rising healthcare expenditure.
Read More
The Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market size is expected to reach $5.88 billion in 2030 at a CAGR of 18.9%, driven by rising cell and gene therapy trials.
Read More
The Gene Therapy Bioassays market size is expected to reach $2.62 billion in 2030 at a CAGR of 16.7%, driven by rising gene therapy clinical trials.
Read More